中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共1278条,第1-10条 帮助

条数/页: 排序方式:
ANTITUMOR ACTIVITY OFGYTOGHALASIN D 期刊论文  OAI收割
JOURNAL OF ANTIBIOTICS, 2025, 页码: 722-723
作者:  
Wen-Jie Guo;  Guan-Jun Tao;  Wen-Yi Tao;  Feng-Jie Cui;  Xian-Chun Jin
  |  收藏  |  浏览/下载:200/0  |  提交时间:2017/07/19
Development of Potent MALT1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidin-7(6H)-one" Scaffold for the Treatment of B Cell Lymphoma 期刊论文  OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 67, 期号: 4, 页码: 2884-2906
作者:  
Liang, Xuewu;  Yu, Haolan;  Liang, Renwen;  Feng, Zhuanghui;  Saidahmatov, Abdusaid
  |  收藏  |  浏览/下载:13/0  |  提交时间:2024/04/09
pH-responsive nanogels with enhanced antioxidant and antitumor activities on drug delivery and smart drug release 期刊论文  OAI收割
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 卷号: 257, 页码: 16
作者:  
Ma, Bing;  Li, Qing;  Mi, Yingqi;  Zhang, Jingjing;  Tan, Wenqiang
  |  收藏  |  浏览/下载:5/0  |  提交时间:2024/01/26
PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma 期刊论文  OAI收割
CANCER RESEARCH, 2024, 卷号: 84, 期号: 3, 页码: 419-433
作者:  
Tao, Hongru;  Jin, Chen;  Zhou, Liyuan;  Deng, Zhenzhong;  Li, Xiao
  |  收藏  |  浏览/下载:10/0  |  提交时间:2024/04/09
A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatory 期刊论文  OAI收割
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 卷号: 127, 页码: 14
作者:  
Zhang, Hui;  Hu, Ke;  Lu, Yumeng;  Xu, Zhijian;  Chen, Gege
  |  收藏  |  浏览/下载:8/0  |  提交时间:2024/03/25
Discovery, Optimization, and Evaluation of Novel Pyridin-2(1H)-one Analogues as Potent TRK Inhibitors for Cancer Treatment 期刊论文  OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 67, 期号: 2, 页码: 1168-1183
作者:  
Xu, Zichao;  Peng, Xia;  Zhang, Renjie;  Ji, Yinchun;  You, Mengke
  |  收藏  |  浏览/下载:9/0  |  提交时间:2024/02/27
SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2024, 页码: 10
作者:  
Li, Wen-jing;  Xie, Cheng-ying;  Zhu, Xi;  Tang, Jiao;  Wang, Lei
  |  收藏  |  浏览/下载:2/0  |  提交时间:2024/02/19
Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRASG12D 期刊论文  OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 67, 期号: 2, 页码: 1147-1167
作者:  
Zhou, Chuan;  Fan, Zisheng;  Gu, Yuejiao;  Ge, Zhiming;  Tao, Zhaofan
  |  收藏  |  浏览/下载:8/0  |  提交时间:2024/02/27
From bench to bedside: current development and emerging trend of KRAS-targeted therapy 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2023, 页码: 18
作者:  
Chen, Yi;  Liu, Qiu-pei;  Xie, Hua;  Ding, Jian
  |  收藏  |  浏览/下载:26/0  |  提交时间:2024/01/16
Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma 期刊论文  OAI收割
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 12, 页码: 4748-4764
作者:  
Liu, Yingqiang;  Zhan, Zhengsheng;  Kang, Zhuang;  Li, Mengyuan;  Lv, Yongcong
  |  收藏  |  浏览/下载:9/0  |  提交时间:2024/01/26